WASHINGTON — Current and former government officials proffered a clear-eyed, and often depressing, take Tuesday on the state of clinical trials, the pharmaceutical industry, and
WASHINGTON (AP) — As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical
Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s office after a nearly two-year effort to install a permanent
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson & Johnson on Tuesday
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. By the numbers Q3 sales: $1.75 billion
Diabetes technology companies remain focused on Type 2 diabetes as a source of growth. Despite the questions from investors on GLP-1 drugs that have peppered
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Attorneys general from 25 states
AWH ANNOUNCES Q3 2023 FINANCIAL RESULTS Reported Record Quarterly Revenue for 6th Consecutive Quarter Achieved $141.3M Net Revenue in Q3 2023, a 27.0% Increase Year-Over-Year
The number of babies born with congenital syphilis in the United States has soared over the last decade, leading to an increase in stillbirths, infant
Making good on a recent threat, the U.S. Federal Trade Commission is challenging more than 100 patents on brand-name medicines that were improperly or inaccurately